Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20160818029414N5Phase 3Completed
Phase 3, randomised, double-blind trial of ephedrine and ondansetron in hypotension (3 arms), sponsored by Zanjan University of Medical Sciences. Primary endpoint: Blood pressure. Started Nov 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20160818029414N5.